Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.

Surgalign Holdings, Inc.

Xtant Medical is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal fixation systems.

msh id	COM:SURGALIGN
symbol	SRGA
name	Surgalign Holdings, Inc.
homepage url	https://www.surgalign.com
country	US
sector	Healthcare
industry	Medical - Devices
market	STOCKS
employee count	217
crunchbase url	-
linkedin url	-
founders	-

market cap	1.68M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.06
growth cost of revenue	0.4
growth depreciation and amortization	-0.13
growth ebitda	-4.66
growth ebitda ratio	-5.04
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-0.08
growth gross profit	-0.34
growth gross profit ratio	-0.27

COM:SURGALIGN

Xtant Medical

Last Close

0.18

14/11 21:00

Market Cap

1.68M

Beta: -

Volume Today

8.72M

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	152.42M
cost of revenue	152.42M
depreciation and amortization	2.16M
ebitda	-68.28M
ebitda ratio	-0.83
eps	-8.33
eps diluted	-8.33
operating expenses	110.73M
operating income	-70.44M
operating income ratio	-0.86

accounts receivables	1.18M
capital expenditure	-7.26M
cash at beginning of period	51.29M
cash at end of period	16.3M
inventory	17.71M
working capital ttm	33.45M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-